Abstract
Background
The purpose of present study was to reveal the molecular mechanisms responsible for both adipogenic differentiation and dedifferentiation of mesenchymal stem cells (MSCs).
Methods
Microarray data GSE36923 were obtained from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) between adipogenically differentiated cells vs undifferentiated bone marrow-derived MSCs, adipogenically differentiated cells vs dedifferentiated cells samples at day 7 and adipogenically differentiated cells vs dedifferentiated cells samples at day 35 were screened, and overlapped DEGs across the three groups were analyzed. The underlying functions of the upregulated and downregulated DEGs were investigated by Gene ontology enrichment and Kyoto Encyclopedia of Genes and Genomes pathway analysis. The protein–protein interaction network was constructed, and hub genes were obtained subsequently. Hub genes were verified with GSE113253 dataset, and then miRNA-gene network and TF-gene network were constructed.
Results
A total of 284 upregulated DEGs and 376 downregulated DEGs overlapped across the three groups. PPAR signaling pathway, AMPK signaling pathway, insulin signaling pathway, carbon metabolism, pyruvate metabolism, fatty acid metabolism, regulation of lipolysis in adipocytes, biosynthesis of amino acids, citrate cycle (TCA cycle) and 2-Oxocarboxylic acid metabolism were the top 10 pathways involving in the upregulated DEGs, and graft-versus-host disease, allograft rejection, viral myocarditis, cell adhesion molecules, phagosome, type I diabetes mellitus, antigen processing and presentation, autoimmune thyroid disease, intestinal immune network for IgA production and rheumatoid arthritis were the top 10 pathways in downregulated DEGs. After validation, the 8 hub genes were IL6, PPARG, CCL2, FASN, CEBPA, ADIPOQ, FABP4 and LIPE. Ten key miRNAs were hsa-mir-27a-3p, hsa-mir-182-5p, hsa-mir-7-5p, hsa-mir-16-5p, hsa-mir-1-3p, hsa-mir-155-5p, hsa-mir-21-3p, hsa-mir-34a-5p, hsa-mir-27a-5p and hsa-mir-30c-5p, and 10 key TFs were TFDP1, GTF2A2, ZNF584, NRF1, ZNF512, NFRKB, CEBPG, KLF16, GLIS2 and MXD4.
Conclusion
Our study constructed miRNA-gene network and TF-gene network involved in both adipogenic differentiation and dedifferentiation of MSCs, contributing to enhancing the efficiency of MSCs transplantation in soft tissue defect repair and developing more potent remedies for adipogenesis-related skeletal disorders.
Similar content being viewed by others
Background
Mesenchymal stem cells (MSCs) are multipotent stromal cells that could differentiate into adipogenic, osteogenic, chondrogenic and other lineages[1]. MSCs derive from many tissues, such as bone marrow, umbilical cord, placenta, skin and fat[2]. MSCs has attracted increasing interest in regenerative medicine for easy isolation, rapid proliferation, low immunogenicity and multilineage differentiation potential[3]. Adipogenic differentiation is an important direction of MSCs differentiation for that it plays an important role in soft tissue defect repair in traumatology[4]. Moreover, excessive adipogenic differentiation of MSCs is related to skeletal diseases such as osteoporosis and osteonecrosis[5, 6]. Therefore, regulation of adipogenic differentiation of MSCs is of great importance for clinical work in orthopedics.
Adipogenic differentiation has been regarded as an irreversible terminal process for a long time[7]. However, Sugihara et al.[8, 9] first found that mature adipocytes could dedifferentiated into fibroblast-like cells using ceiling culture technology. These fibroblast-like cells, termed dedifferentiated fat cells, possess stem cell properties, and can re-differentiate to multiple mesenchymal cell lineages[10]. Adipocyte differentiation and dedifferentiation are two opposite processes, however, the mechanisms responsible for adipocyte dedifferentiation remain largely unknown. Generally, genes and pathways that are required for adipogenesis are also essential for dedifferentiation[11]. The mechanism involved in both adipogenic differentiation and dedifferentiation may become a key to regulating MSC adipogenesis.
Adipogenic differentiation and dedifferentiation may involve signaling pathways including PPARγ pathway[12, 13], Wnt/β-catenin pathway[14, 15], transforming growth factor-β pathway[16, 17], and Notch signaling pathway[13, 18]. Moreover, microRNAs such as miR-377-3p[19] and miR-431[20] and transcription factors (TFs) like FOXN1[21] and TEAD4[22] may also be involved in the adipogenic differentiation. The role of microRNAs and TFs in adipocyte dedifferentiation, however, remains largely unknown. Therefore, molecular mechanism of MSCs adipogenic differentiation and dedifferentiation is complicated, and it is necessary to elucidate that for further application.
To explore the molecular mechanisms responsible for the adipogenic differentiation and dedifferentiation of MSCs, we screened the differentially expressed genes (DEGs) of microarray data GSE36923. Subsequently, comprehensive bioinformatics methods were used to analyze the functions and potential pathways of DEGs. In addition, protein–protein interaction (PPI) network was performed to elucidate the underlying molecular mechanisms. Hub genes were calculated and then validated using dataset GSE113253. Furthermore, TFs and miRNAs targeting the hub genes were predicted, and miRNA-gene network and TF-gene network were constructed.
Methods
Microarray data
The gene expression profile of GSE36923 was downloaded from Gene Expression Omnibus database (GEO, http://www.ncbi.nlm.nih.gov/geo/). GSE36923 was based on the Affymetrix GPL570 platform (Affymetrix Human Genome U133 Plus 2.0 Array, Santa Clara, CA, USA). The GSE36923 dataset contained 12 samples, including 3 undifferentiated bone marrow-derived MSCs (BMSCs) samples, 3 adipogenically differentiated cells samples at d 15, 3 dedifferentiated cells samples at d 7 and 3 dedifferentiated cells samples at d 35. MSCs features, adipogenic differentiation and dedifferentiation method were showed as Ullah, M et al. described[23].
Screening of differentially expressed genes
NetworkAnalyst (https://www.networkanalyst.ca/NetworkAnalyst/), an online platform of transcriptome profiling, network analysis, and meta-analysis for gene expression data[24], was used to screen DEGs from the gene expression data. Data was normalized by variance stabilizing normalization followed by quantile normalization. Box plots for expression data were generated. DEGs (adipogenically differentiated cells vs undifferentiated MSCs, adipogenically differentiated cells vs dedifferentiated cells samples at d 7 and adipogenically differentiated cells vs dedifferentiated cells samples at d 35) were screened with the criteria of adjust P value < 0.05 and |logFC (fold change)|≥ 1. Overlapped DEGs across the three groups were analyzed and visualized using R software (version 3.6.3; https://www.r-project.org/) and ggplot2 package (version 3.3.3). Heatmap indicating all overlaps between up- and downregulated genes for all comparisons was visualized using R software (version 3.6.3; https://www.r-project.org/) and pheatmap package (version 1.0.12).
Gene ontology enrichment and KEGG pathway analysis
Gene ontology (GO) enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis of upregulated and downregulated DEGs were performed using R software (version 3.6.3; https://www.r-project.org/) and clusterProfiler packages (version 3.14.3)[25]. P value < 0.05 was considered to indicate a statistical significance.
PPI network construction and hub genes selection
The PPI network was constructed using The Search Tool for the Retrieval of Interacting Genes/Proteins (http://string-db.org)[26] with the threshold of minimum required interaction score > 0.4. Network and node file were generated and further analyzed using Cytoscape software (version 3.8.2; www.cytoscape.org). Cytoscape's plug-in cytoHubba was used to identify top 100 key genes by degree algorithm, and the PPI network of top 100 key genes was constructed.
Hub genes validation
Top ten hub genes were further validated in GSE113253, downloaded from the GEO database. The dataset was based on the platform of GPL18460 (Illumina HiSeq 1500), in which 3 undifferentiated BMSCs and 3 adipogenically differentiated cells samples at d 14 were selected. MSCs features and adipogenic differentiation method were showed as Rauch et al. described [27]. DEGs were identified with Student’s t-test. P value of < 0.05 was considered statistically significant.
MiRNA-target gene network and TF-target gene network construction
After validation, eight genes (IL6, PPARG, CCL2, FASN, CEBPA, ADIPOQ, FABP4, LIPE) were selected as target genes. MiRNA-target gene network and TF-target gene network were analyzed using TarBase (version 8.0; https://dianalab.e-ce.uth.gr/html/diana/web/index.php?r=tarbasev8) and ENCODE software package (http://cistrome.org/BETA/) in NetworkAnalyst, and were visualized by employing Cytoscape software. Top 10 key miRNAs and TFs were identified with cytoHubba by degree algorithm.
Results
Identification of DEGs during MSC adipogenesis and dedifferentiation
After normalization (Fig. 1), 659, 869 and 686 DEGs were upregulated and 933, 1258 and 1042 DEGs were downregulated in adipogenically differentiated cells vs undifferentiated MSCs, adipogenically differentiated cells vs dedifferentiated cells samples at d 7 and adipogenically differentiated cells vs dedifferentiated cells samples at d 35, respectively. A total of 284 upregulated DEGs and 376 downregulated DEGs overlapped across the three groups (Fig. 2) and were shown in the heatmap (Fig. 3).
GO enrichment and KEGG pathway analysis
In order to elucidate the functions of overlapped DEGs, upregulated and downregulated genes were further analyzed for functional enrichment, respectively. With regard to the molecular function, upregulated DEGs (Fig. 4A) mainly showed enrichment in the coenzyme binding, oxidoreductase activity, acting on CH-OH group of donors, oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor, lyase activity, NAD binding and oxidoreductase activity, acting on the CH-CH group of donors, and downregulated DEGs (Fig. 4B) mainly showed enrichment in the peptide antigen binding, metalloendopeptidase inhibitor activity, extracellular matrix structural constituent, MHC class II receptor activity, collagen binding and glycosaminoglycan binding. For the cellular component ontology (Fig. 4A), commonly enriched categories were associated with mitochondrial matrix, lipid droplet, mitochondrial inner membrane, peroxisome, microbody and organelle outer membrane in upregulated DEGs, and were associated with MHC protein complex, integral component of lumenal side of endoplasmic reticulum membrane, lumenal side of endoplasmic reticulum membrane, MHC class II protein complex, collagen-containing extracellular matrix and ER to Golgi transport vesicle membrane in downregulated DEGs (Fig. 4B). For the biological process (Fig. 5A), fatty acid metabolic process, alcohol metabolic process, response to peptide hormone, response to insulin, regulation of small molecule metabolic process and regulation of lipid metabolic process were the commonly enriched categories in upregulated DEGs, and interferon-gamma-mediated signaling pathway, response to interferon-gamma, antigen processing and presentation of peptide antigen, antigen processing and presentation of exogenous peptide antigen, tissue remodeling and cellular response to interferon-gamma in downregulated DEGs (Fig. 4B). PPAR signaling pathway, AMPK signaling pathway, insulin signaling pathway, carbon metabolism, pyruvate metabolism, fatty acid metabolism, regulation of lipolysis in adipocytes, biosynthesis of amino acids, citrate cycle (TCA cycle) and 2-Oxocarboxylic acid metabolism were the top 10 pathways involving in the upregulated DEGs (Fig. 5A), and graft-versus-host disease, allograft rejection, viral myocarditis, cell adhesion molecules, phagosome, type I diabetes mellitus, antigen processing and presentation, autoimmune thyroid disease, intestinal immune network for IgA production and rheumatoid arthritis in downregulated DEGs (Fig. 5B).
Protein–protein interaction network
The protein–protein interaction network of top 100 key genes is shown in Fig. 6. The top 10 high-degree hub nodes were IL6, PPARG, CCL2, FASN, SREBF1, SCD, CEBPA, ADIPOQ, FABP4 and LIPE.
Validation of hub genes expression
Ten hub genes were validated using the GSE113253 dataset. For upregulated hub genes, compared to undifferentiated MSCs, the expressions of PPARG, FASN, CEBPA, ADIPOQ, FABP4 and LIPE were consistently increased in adipogenically differentiated cells (Fig. 7B, D, G–J). For downregulated hub genes, the expression of IL6 and CCL2 also decreased during adipogenesis (Fig. 7A, C). Results demonstrated that IL6, PPARG, CCL2, FASN, CEBPA, ADIPOQ, FABP4 and LIPE were pivotal genes involved in adipogenic differentiation and dedifferentiation of MSCs (Table 1).
MiRNA-target gene interaction network construction
174 miRNAs targeting 8 target hub genes were obtained in NetworkAnalyst using TarBase (version 8.0), and an additional table file shows this in more detail [see Additional file 1]. The miRNA-target gene interaction network was constructed with cytoscape (Fig. 8). According to the nodes’ degree value, top 10 key miRNAs were hsa-mir-27a-3p, hsa-mir-182-5p, hsa-mir-7-5p, hsa-mir-16-5p, hsa-mir-1-3p, hsa-mir-155-5p, hsa-mir-21-3p, hsa-mir-34a-5p, hsa-mir-27a-5p and hsa-mir-30c-5p.
TF-target gene interaction network construction
135 TFs targeting 8 hub genes were obtained in NetworkAnalyst using ENCODE software package, and an additional table file shows this in more detail [see Additional file 2]. The TF-target gene interaction network was also constructed with cytoscape (Fig. 9). According to the nodes’ degree value, top 10 key TFs were TFDP1, GTF2A2, ZNF584, NRF1, ZNF512, NFRKB, CEBPG, KLF16, GLIS2 and MXD4.
Discussion
MSCs are promising seed cells in tissue engineering. These cells are usually applied in restoring large-sized soft tissue defects resulting from trauma, musculoskeletal tumor resection and congenital defects for their adipogenetic ability [28]. However, adipocyte dedifferentiation would occur after transplantation [29]. Moreover, MSCs adipogenesis is correlated with diseases like osteoporosis and osteonecrosis. Complete elucidation of the mechanism underlying the adipogenetic differentiation and dedifferentiation could contribute to designing better seed cells based on MSCs in tissue engineering and discovering more effective treatments for skeletal diseases related to adipogenesis [11].
In this study, we analyzed DEGs of adipogenically differentiated MSCs and undifferentiated MSCs, adipogenically differentiated MSCs and dedifferentiated MSCs at d 7, and adipogenically differentiated MSCs vs dedifferentiated MSCs at d 35, respectively. Overlapped DEGs across the three groups contained 284 upregulated genes and 376 downregulated genes. GO and KEGG pathway analyses were carried out to find the interactions of DEGs. For the upregulated DEGs, pathway enrichment analysis revealed that PPAR signaling pathway was significantly enriched. PPAR-γ has been reported to be one of the important genetic factors in the MSCs adipogenic differentiation and dedifferentiation, and PPAR signaling pathway plays a role in the regulation of adipocyte differentiation and dedifferentiation [11, 30,31,32]. For the downregulated DEGs, pathway enrichment analysis revealed that the graft-versus-host disease (GVHD) was significantly enriched. Qi et al. [33] revealed that the adipogenic differentiation capacity was decreased in the active chronic GVHD MSCs compared with no-cGVHD MSCs. The adipogenesis of MSCs may be negatively associated with GVHD disease, which was in line with the results of the present study.
After PPI network construction and validation, we found 8 hub genes including IL6, PPARG, CCL2, FASN, CEBPA, ADIPOQ, FABP4 and LIPE. PPARG, FASN, SREBF1, SCD, CEBPA, ADIPOQ, FABP4 are key adipogenic markers, and activation expression of these genes could enhance the adipogenic differentiation of MSCs [34,35,36,37,38]. PPARG, CEBPA, ADIPOQ and FABP4 are involved in adipogenesis, and FASN is involved in lipogenesis. Ullah et al. [23] had confirmed that the expression of ADIPOQ and FABP4 upregulated at adipogenic differentiation d 15 compared to undifferentiated MSCs d 0, and downregulated during dedifferentiation. LIPE, a gene related to lipolysis, plays a key role in the regulation of adipose tissue deposition [39, 40]. Yi et al. [41] found that the expression of ADIPOQ, CEBPA, FABP4, FASN AND LIPE were significantly higher during adipogenesis of MSCs by the RNA-Seq technique, which is consistent with our results. Liao et al. [42] found that the expression of PPARG, CEBPA and ADIPOQ was significantly downregulated in vivo dedifferentiation of adult adipose cells. Cote et al. [43] explored the changes in gene expression profile during human mature adipocyte dedifferentiation, they also found that the expression of LIPE, ADIPOQ, CEBPA AND FABP4 decreased when human mature adipocyte dedifferentiated from d 7 to d 12. However, they used ceiling culture technique for adipocyte dedifferentiation, which is different with our study. IL6 is a known regulator of adipose homeostasis in obesity and is high secreted from adipose tissue [44, 45]. It involves in obesity-associated metabolic complications [45]. Moreover, IL6 involves in differentiation of MSCs. IL6 could enhance osteogenetic and myogenetic differentiation of MSCs [46,47,48]. Huang et al. [49] found that IL6 potentiated BMP-2-induced osteogenesis and adipogenesis of BMSCs by amplifying BMPR1A-mediated BMP/Smad and p38 MAPK pathways, respectively. CCL2 is a chemokine that plays an important role in inflammation and indirectly involves in the process of adipogenesis via inflammatory responses. Zhu et al. [50] revealed that CCL2 directly promoted adipogenesis of MSCs in vitro possibly by enhancing AKT phosphorylation.
Among these 10 hub miRNAs, we found that the interactions between adipogenesis and hub miRNAs hsa-mir-21-3p, hsa-mir-27a-5p and hsa-mir-30c-5p have not been reported. MiR-27-3p exerts an inhibitory effect on adipogenesis by repressing PPARγ [51, 52]. Ding et al. [53] found that circPTK2 promoted lipolysis and inhibited adipogenesis through binding to miR-182-5p. Chen et al. [54] found that CDR1as-miR-7-5p-WNT5B axis might play crucial role in adipogenic/osteogenic differentiation disorder of BMSCs from steroid-induced osteonecrosis of the femoral head patients. Xu et al. [55] found that miR-16-5p promoted adipocyte differentiation by suppressing EPT1. Gu et al. [56] found that miR-1-3p was upregulated during osteogenesis but downregulated during adipogenesis of mouse MSCs. Du et al. [57] found that hsa-miR-1-3p was one of hub miRNAs coregulated both osteogenic and adipogenic differentiation. Eseberri et al. [58] found that resveratrol and glucuronide metabolites inhibited adipogenesis through upregulating miR-155 expression. Meruvu et al. [59] found that butyl benzyl phthalate promoted adipogenesis via the miRNA-34a-5p signaling pathway.
Among these 10 hub TFs, we found that the interactions between adipogenesis and hub TFs TFDP1, GTF2A2, ZNF584, ZNF512, NFRKB and GLIS2 have not been reported. Xue et al. [60] found that long isoforms of NRF1 was a negative regulator of PPARγ expression to suppress adipogenesis. CEBPG is one of potential TFs involved in adipogenesis[61]. Jang et al.[62] found that KLF16 inhibited adipogenesis through downregulating PPARγ expression. However, Cui et al. [63] found that when the FGF1 upregulated, adipocytes accumulation accelerated, while the expression of KLF16 increased significantly at the same time. Li et al. [64] found that over-expression of MXD4 could inhibit adipogenesis of human adipose-derived stem cells.
Conclusions
In conclusion, we have identified key genes, miRNAs and TFs involved in both adipogenic differentiation and dedifferentiation of MSCs by bioinformatical analyses and constructed the miRNA-gene network and TF-gene network. These findings could improve our understanding of adipogenic differentiation and dedifferentiation of stem cells, contributing to enhancing the efficiency of MSCs transplantation in soft tissue defect repair and developing more potent remedies for adipogenesis-related skeletal disorders.
Availability of data and materials
The datasets supporting the conclusions of this article are available in the Gene Expression Omnibus repository, https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE36923 and https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE113253.
Abbreviations
- MSCs:
-
Mesenchymal stem cells
- DEGs:
-
Differentially expressed genes
- PPI:
-
Protein–protein interaction
- BMSCs:
-
Bone marrow-derived mesenchymal stem cells
- GO:
-
Gene ontology
- KEGG:
-
Kyoto encyclopedia of genes and genomes
- GVHD:
-
Graft-versus-host disease
References
Han Y, Li X, Zhang Y, et al. Mesenchymal stem cells for regenerative medicine. Cells. 2019;8.
da Silva ML, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci. 2006;119:2204–13.
Chu DT, Phuong TNT, Tien NLB, et al. An update on the progress of isolation, culture, storage, and clinical application of human bone marrow mesenchymal stem/stromal cells. Int J Mol Sci. 2020;21.
Liu X, Li Z, Liu H, et al. Flufenamic acid inhibits adipogenic differentiation of mesenchymal stem cells by antagonizing the PI3K/AKT signaling pathway. Stem Cells Int. 2020;2020:1540905.
Lin Z, He H, Wang M, et al. MicroRNA-130a controls bone marrow mesenchymal stem cell differentiation towards the osteoblastic and adipogenic fate. Cell Prolif. 2019;52: e12688.
Sheng HH, Zhang GG, Cheung WH, et al. Elevated adipogenesis of marrow mesenchymal stem cells during early steroid-associated osteonecrosis development. J Orthop Surg Res. 2007;2:15.
Liu S, Wang L, Ling D, et al. Potential key factors involved in regulating adipocyte dedifferentiation. J Cell Physiol. 2022;237:1639–47.
Sugihara H, Yonemitsu N, Miyabara S, et al. Proliferation of unilocular fat cells in the primary culture. J Lipid Res. 1987;28:1038–45.
Sugihara H, Yonemitsu N, Miyabara S, et al. Primary cultures of unilocular fat cells: characteristics of growth in vitro and changes in differentiation properties. Differentiation. 1986;31:42–9.
Matsumoto T, Kano K, Kondo D, et al. Mature adipocyte-derived dedifferentiated fat cells exhibit multilineage potential. J Cell Physiol. 2008;215:210–22.
Song T, Kuang S. Adipocyte dedifferentiation in health and diseases. Clin Sci (Lond). 2019;133:2107–19.
Yuan Z, Li Q, Luo S, et al. PPARγ and Wnt signaling in adipogenic and osteogenic differentiation of mesenchymal stem cells. Curr Stem Cell Res Ther. 2016;11:216–25.
Bi P, Yue F, Karki A, et al. Notch activation drives adipocyte dedifferentiation and tumorigenic transformation in mice. J Exp Med. 2016;213:2019–37.
Ambele MA, Dhanraj P, Giles R, et al. Adipogenesis: a complex interplay of multiple molecular determinants and pathways. Int J Mol Sci. 2020;21.
Gustafson B, Smith U. Activation of canonical wingless-type MMTV integration site family (Wnt) signaling in mature adipocytes increases beta-catenin levels and leads to cell dedifferentiation and insulin resistance. J Biol Chem. 2010;285:14031–41.
Margoni A, Fotis L, Papavassiliou AG. The transforming growth factor-beta/bone morphogenetic protein signalling pathway in adipogenesis. Int J Biochem Cell Biol. 2012;44:475–9.
Côté JA, Lessard J, Pelletier M, et al. Role of the TGF-β pathway in dedifferentiation of human mature adipocytes. FEBS Open Bio. 2017;7:1092–101.
Liu MC, Logan H, Newman JJ. Distinct roles for Notch1 and Notch3 in human adipose-derived stem/stromal cell adipogenesis. Mol Biol Rep. 2020;47:8439–50.
Li X, Yang Y, Yan R, et al. miR-377-3p regulates adipogenic differentiation of human bone marrow mesenchymal stem cells by regulating LIFR. Mol Cell Biochem. 2018;449:295–303.
Wang Y, Yang L, Liu X, et al. miR-431 inhibits adipogenic differentiation of human bone marrow-derived mesenchymal stem cells via targeting insulin receptor substance 2. Stem Cell Res Ther. 2018;9:231.
Walendzik K, Kopcewicz M, Bukowska J, et al. The transcription factor FOXN1 regulates skin adipogenesis and affects susceptibility to diet-induced obesity. J Invest Dermatol. 2020;140(1166–75): e9.
Zhang W, Xu J, Li J, et al. The TEA domain family transcription factor TEAD4 represses murine adipogenesis by recruiting the cofactors VGLL4 and CtBP2 into a transcriptional complex. J Biol Chem. 2018;293:17119–34.
Ullah M, Stich S, Notter M, et al. Transdifferentiation of mesenchymal stem cells-derived adipogenic-differentiated cells into osteogenic- or chondrogenic-differentiated cells proceeds via dedifferentiation and have a correlation with cell cycle arresting and driving genes. Differentiation. 2013;85:78–90.
Zhou G, Soufan O, Ewald J, et al. NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis. Nucleic Acids Res. 2019;47:W234–41.
Wu T, Hu E, Xu S, et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation (Camb). 2021;2:100141.
Szklarczyk D, Gable AL, Nastou KC, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2021;49:D605–12.
Rauch A, Haakonsson AK, Madsen JGS, et al. Osteogenesis depends on commissioning of a network of stem cell transcription factors that act as repressors of adipogenesis. Nat Genet. 2019;51:716–27.
Wu L, Wang T, Ge Y, et al. Secreted factors from adipose tissue increase adipogenic differentiation of mesenchymal stem cells. Cell Prolif. 2012;45:311–9.
Chai Y, Chen Y, Yin B, et al. Dedifferentiation of human adipocytes after fat transplantation. Aesthet Surg J. 2022;42:np423–31.
Shao X, Wang M, Wei X, et al. Peroxisome proliferator-activated receptor-gamma: master regulator of adipogenesis and obesity. Curr Stem Cell Res Ther. 2016;11:282–9.
Wang Y, Gao R, Wang PP, et al. The differential effects of aligned electrospun PHBHHx fibers on adipogenic and osteogenic potential of MSCs through the regulation of PPARγ signaling. Biomaterials. 2012;33:485–93.
Wu L, Ma F, Zhao X, et al. GNPDA2 gene affects adipogenesis and alters the transcriptome profile of human adipose-derived mesenchymal stem cells. Int J Endocrinol. 2019;2019:9145452.
Qi HZ, Ye YL, Suo Y, et al. Wnt/beta-catenin signaling mediates the abnormal osteogenic and adipogenic capabilities of bone marrow mesenchymal stem cells from chronic graft-versus-host disease patients. Cell Death Dis. 2021;12:308.
Salehpour A, Shidfar F, Hedayati M, et al. Molecular mechanisms of vitamin D plus Bisphenol A effects on adipogenesis in human adipose-derived mesenchymal stem cells. Diabetol Metab Syndr. 2021;13:41.
Salehpour A, Hedayati M, Shidfar F, et al. 1,25-Dihydroxyvitamin D3 modulates adipogenesis of human adipose-derived mesenchymal stem cells dose-dependently. Nutr Metab (Lond). 2021;18:29.
Ibrahim M, Jang M, Park M, et al. Capsaicin inhibits the adipogenic differentiation of bone marrow mesenchymal stem cells by regulating cell proliferation, apoptosis, oxidative and nitrosative stress. Food Funct. 2015;6:2165–78.
Luo J, Dou L, Yang Z, et al. CBFA2T2 promotes adipogenic differentiation of mesenchymal stem cells by regulating CEBPA. Biochem Biophys Res Commun. 2020;529:133–9.
Comas F, Latorre J, Ortega F, et al. Permanent cystathionine-β-Synthase gene knockdown promotes inflammation and oxidative stress in immortalized human adipose-derived mesenchymal stem cells, enhancing their adipogenic capacity. Redox Biol. 2021;42: 101668.
Al-Thuwaini TM, Al-Shuhaib MBS, Lepretre F, et al. Co-inherited novel SNPs of the LIPE gene associated with increased carcass dressing and decreased fat-tail weight in Awassi breed. Trop Anim Health Prod. 2020;52:3631–8.
Zhang X, Zhang CC, Yang H, et al. An epistatic interaction between Pnpla2 and Lipe reveals new pathways of adipose tissue lipolysis. Cells. 2019;8.
Yi X, Liu J, Wu P, et al. The whole transcriptional profiling of cellular metabolism during adipogenesis from hMSCs. J Cell Physiol. 2020;235:349–63.
Liao Y, Zeng Z, Lu F, et al. In vivo dedifferentiation of adult adipose cells. PLoS ONE. 2015;10: e0125254.
Cote JA, Guenard F, Lessard J, et al. Temporal changes in gene expression profile during mature adipocyte dedifferentiation. Int J Genomics. 2017;2017:5149362.
Cuzzone DA, Weitman ES, Albano NJ, et al. IL-6 regulates adipose deposition and homeostasis in lymphedema. Am J Physiol Heart Circ Physiol. 2014;306:H1426–34.
Wueest S, Konrad D. The role of adipocyte-specific IL-6-type cytokine signaling in FFA and leptin release. Adipocyte. 2018;7:226–8.
Fukuyo S, Yamaoka K, Sonomoto K, et al. IL-6-accelerated calcification by induction of ROR2 in human adipose tissue-derived mesenchymal stem cells is STAT3 dependent. Rheumatology (Oxford). 2014;53:1282–90.
Bastidas-Coral AP, Bakker AD, Zandieh-Doulabi B, et al. Cytokines TNF-alpha, IL-6, IL-17F, and IL-4 differentially affect osteogenic differentiation of human adipose stem cells. Stem Cells Int. 2016;2016:1318256.
Bastidas-Coral AP, Hogervorst JMA, Forouzanfar T, et al. IL-6 counteracts the inhibitory effect of IL-4 on osteogenic differentiation of human adipose stem cells. J Cell Physiol. 2019;234:20520–32.
Huang RL, Sun Y, Ho CK, et al. IL-6 potentiates BMP-2-induced osteogenesis and adipogenesis via two different BMPR1A-mediated pathways. Cell Death Dis. 2018;9:144.
Zhu Z, Guo L, Yeltai N, et al. Chemokine (C-C motif) ligand 2-enhanced adipogenesis and angiogenesis of human adipose-derived stem cell and human umbilical vein endothelial cell co-culture system in adipose tissue engineering. J Tissue Eng Regen Med. 2022;16:163–76.
Wu H, Pula T, Tews D, et al. microRNA-27a-3p but Not -5p Is a crucial mediator of human adipogenesis. Cells. 2021;10.
Shen X, Tang J, Huang Y, et al. CircRNF111 Contributes to adipocyte differentiation by elevating PPARγ expression via miR-27a-3p. epigenetics. 2022:1–15.
Ding Z, Sun D, Han J, et al. Novel noncoding RNA CircPTK2 regulates lipolysis and adipogenesis in cachexia. Mol Metab. 2021;53: 101310.
Chen G, Wang Q, Li Z, et al. Circular RNA CDR1as promotes adipogenic and suppresses osteogenic differentiation of BMSCs in steroid-induced osteonecrosis of the femoral head. Bone. 2020;133: 115258.
Xu J, Zhang L, Shu G, et al. microRNA-16-5p promotes 3T3-L1 adipocyte differentiation through regulating EPT1. Biochem Biophys Res Commun. 2019;514:1251–6.
Gu H, Shi S, Xiao F, et al. MiR-1-3p regulates the differentiation of mesenchymal stem cells to prevent osteoporosis by targeting secreted frizzled-related protein 1. Bone. 2020;137: 115444.
Du G, Cheng X, Zhang Z, et al. TGF-beta induced key genes of osteogenic and adipogenic differentiation in human mesenchymal stem cells and MiRNA-mRNA regulatory networks. Front Genet. 2021;12: 759596.
Eseberri I, Lasa A, Miranda J, et al. Potential miRNA involvement in the anti-adipogenic effect of resveratrol and its metabolites. PLoS ONE. 2017;12: e0184875.
Meruvu S, Zhang J, Choudhury M. Butyl benzyl phthalate promotes adipogenesis in 3T3-L1 cells via the miRNA-34a-5p signaling pathway in the absence of exogenous adipogenic stimuli. Chem Res Toxicol. 2021;34:2251–60.
Xue P, Hou Y, Zuo Z, et al. Long isoforms of NRF1 negatively regulate adipogenesis via suppression of PPARgamma expression. Redox Biol. 2020;30: 101414.
Szczerbal I, Chmurzynska A. Chromosomal localization of nine porcine genes encoding transcription factors involved in adipogenesis. Cytogenet Genome Res. 2008;121:50–4.
Jang MK, Lee S, Jung MH. RNA-Seq analysis reveals a negative role of KLF16 in adipogenesis. PLoS ONE. 2016;11: e0162238.
Cui S, Li X, Li R, et al. FGF1 promotes the differentiation of goat intramuscular and subcutaneous preadipocytes. Anim Biotechnol. 2021:1–13.
Li S, Xue T, He F, et al. A time-resolved proteomic analysis of transcription factors regulating adipogenesis of human adipose derived stem cells. Biochem Biophys Res Commun. 2019;511:855–61.
Acknowledgements
Not applicable.
Funding
This research received no external funding.
Author information
Authors and Affiliations
Contributions
OY-Y designed the study, conducted the bioinformatic analysis and performed the statistically analyses. D-MM wrote the draft. OY-Y and D-MM edited and confirmed the final manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
No competing interest was reported by the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Additional file 1.
miRNAs and their degree scores
Additional file 2.
TFs and their descriptions
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Ou-yang, Y., Dai, Mm. Screening for genes, miRNAs and transcription factors of adipogenic differentiation and dedifferentiation of mesenchymal stem cells. J Orthop Surg Res 18, 46 (2023). https://doi.org/10.1186/s13018-023-03514-0
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s13018-023-03514-0